Invios

Developer of immunotherapies for the treatment of cancer

placeVienna, Vienna, Austria calendar_todayFounded 2019 language invios.com

Social engagement

Social engagement: 2.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Ligand Pharmaceuticals.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

16 Mar 2026
Event
AACR Special Conference on Brain Cancer Research
10 Feb 2026
Event
9th CAR-TCR Summit Europe
Coming soon